SAN ANTONIO, Texas, Jan. 12, 2005 (PRIMEZONE) -- FaceKey Corp. (Pink Sheets:FEKY) announced that the Company has begun trading under the ticker symbol FEKY on the Over-the-Counter "Pink Sheets" market. The Company provides security measures for corporations, government agencies, and other institutions' secure areas, PC's and time and attendance systems by utilizing biometric technologies that identify and allow access to authorized personnel.
President and Chief Executive Officer of FaceKey, Yevgeny Levitov, Ph.D, states, "FaceKey is very excited and optimistic about becoming a publicly traded company. We are very confident that with increased access to capital and much greater visibility, our Company has a bright future producing, patenting, and selling biometric technologies to several industry sectors."
FaceKey's technology combines face and fingerprint recognition providing the highest level of security available, reducing fraud and providing better accountability. The Company currently generates revenue from sales of the FaceKey "Standard Access Control" system utilizing face and fingerprint recognition as well as the "PC AccessKey" and "Time and Attendance" Systems which both utilize fingerprint recognition.
About FaceKey Corp.
FaceKey Corp., headquartered in San Antonio, TX, is a biometrics technology provider whose mission is to provide supreme security measures for their customers by utilizing patented and proprietary biometric technologies that identify and allow access to authorized personnel. FaceKey's products can be used for a wide variety of applications ranging from securing corporation's confidential areas and time and access, to confirming the identities of bank customers at an ATM to the future of consumer products that can identify their owner's face and fingerprints.
For more information about the Company, please visit www.facekey.com
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained herein which are not historical are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond the Company's control with respect to market acceptance of new technologies or products, delays in testing, and evaluation of products, and other risks detailed from time to time in the Company's filing with the Securities and Exchange Commission.